Charalampos D. Moschopoulos

758 total citations
21 papers, 361 citations indexed

About

Charalampos D. Moschopoulos is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Charalampos D. Moschopoulos has authored 21 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Emergency Medicine. Recurrent topics in Charalampos D. Moschopoulos's work include HIV-related health complications and treatments (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and HIV Research and Treatment (3 papers). Charalampos D. Moschopoulos is often cited by papers focused on HIV-related health complications and treatments (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and HIV Research and Treatment (3 papers). Charalampos D. Moschopoulos collaborates with scholars based in Greece, Germany and Switzerland. Charalampos D. Moschopoulos's co-authors include Paraskevi C. Fragkou, Chrysanthi Skevaki, Valentijn A. Schweitzer, David S. Y. Ong, Roy F. Chemaly, Dana Yelin, Ili Margalit, Dafna Yahav, J.‐P. Stahl and Effrossyni Gkrania‐Klotsas and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Trends in Molecular Medicine and Clinical Microbiology and Infection.

In The Last Decade

Charalampos D. Moschopoulos

21 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charalampos D. Moschopoulos Greece 8 202 113 57 52 40 21 361
Andreas Lind Norway 11 205 1.0× 91 0.8× 72 1.3× 70 1.3× 24 0.6× 32 383
Seow Yen Tan Singapore 8 326 1.6× 163 1.4× 51 0.9× 46 0.9× 51 1.3× 19 461
Muhammad Umer Ahmed Pakistan 11 197 1.0× 182 1.6× 48 0.8× 60 1.2× 51 1.3× 42 510
Suchitra Rao United States 6 191 0.9× 88 0.8× 24 0.4× 46 0.9× 45 1.1× 12 316
Julia Schädler Germany 8 254 1.3× 133 1.2× 36 0.6× 26 0.5× 18 0.5× 17 401
Parnian Jamshidi Iran 11 206 1.0× 118 1.0× 123 2.2× 49 0.9× 30 0.8× 16 449
Yinghao Cao China 6 202 1.0× 119 1.1× 22 0.4× 24 0.5× 31 0.8× 11 380
Thierry Hernández‐Gilsoul Mexico 8 145 0.7× 69 0.6× 29 0.5× 42 0.8× 12 0.3× 24 272
Mukunthan Murthi United States 7 139 0.7× 76 0.7× 20 0.4× 31 0.6× 16 0.4× 33 282

Countries citing papers authored by Charalampos D. Moschopoulos

Since Specialization
Citations

This map shows the geographic impact of Charalampos D. Moschopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalampos D. Moschopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalampos D. Moschopoulos more than expected).

Fields of papers citing papers by Charalampos D. Moschopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charalampos D. Moschopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalampos D. Moschopoulos. The network helps show where Charalampos D. Moschopoulos may publish in the future.

Co-authorship network of co-authors of Charalampos D. Moschopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Charalampos D. Moschopoulos. A scholar is included among the top collaborators of Charalampos D. Moschopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charalampos D. Moschopoulos. Charalampos D. Moschopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Protopapas, Konstantinos, et al.. (2024). Mpox and Lessons Learned in the Light of the Recent Outbreak: A Narrative Review. Viruses. 16(10). 1620–1620. 6 indexed citations
2.
Dimopoulou, Dimitra, Charalampos D. Moschopoulos, Anastasia Dimopoulou, et al.. (2024). Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review. Antibiotics. 13(11). 1078–1078. 1 indexed citations
3.
Moschopoulos, Charalampos D., Konstantinos Protopapas, Dimitra Kavatha, et al.. (2024). Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review. Life. 14(4). 508–508. 4 indexed citations
4.
Moschopoulos, Charalampos D., Kate Alford, Anastasia Antoniadou, & Jaime H. Vera. (2024). Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives. Trends in Molecular Medicine. 30(11). 1076–1089. 3 indexed citations
5.
Fragkou, Paraskevi C., et al.. (2024). Effects of long-term corticosteroid use on susceptibility to respiratory viruses: a narrative review. Clinical Microbiology and Infection. 31(1). 43–48. 1 indexed citations
6.
Skevaki, Chrysanthi, Charalampos D. Moschopoulos, Paraskevi C. Fragkou, et al.. (2024). Long COVID: Pathophysiology, current concepts, and future directions. Journal of Allergy and Clinical Immunology. 155(4). 1059–1070. 5 indexed citations
7.
Moschopoulos, Charalampos D., Dimitra Dimopoulou, Anastasia Dimopoulou, et al.. (2023). New Insights into the Fluid Management in Patients with Septic Shock. Medicina. 59(6). 1047–1047. 9 indexed citations
8.
Fragkou, Paraskevi C., Ignatios Ikonomidis, Dimitra Kavatha, et al.. (2023). Endothelial Glycocalyx Integrity in Treatment-Naïve People Living with HIV before and One Year after Antiretroviral Treatment Initiation. Viruses. 15(7). 1505–1505. 4 indexed citations
9.
Fragkou, Paraskevi C., Charalampos D. Moschopoulos, Dimitra Dimopoulou, et al.. (2023). Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives. Hellenic Journal of Cardiology. 71. 42–54. 17 indexed citations
10.
Moschopoulos, Charalampos D., Konstantinos Protopapas, Κonstantinos Thomas, et al.. (2022). Switching from Tenofovir Disoproxil to Tenofovir Alafenamide Fumarate: Impact on Cardiovascular Risk and Lipid Profile in People Living with HIV, an Observational Study. AIDS Research and Human Retroviruses. 39(2). 68–75. 3 indexed citations
11.
Fragkou, Paraskevi C., et al.. (2022). Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review. Clinical Microbiology and Infection. 28(10). 1328–1334. 6 indexed citations
12.
Fragkou, Paraskevi C., Charalampos D. Moschopoulos, Dimitra Dimopoulou, et al.. (2022). Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis. Clinical Microbiology and Infection. 29(3). 291–301. 17 indexed citations
13.
Moschopoulos, Charalampos D., Shiran Shapira, Garyphallia Poulakou, et al.. (2022). Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review. Life. 12(10). 1472–1472. 10 indexed citations
14.
Yelin, Dana, Charalampos D. Moschopoulos, Ili Margalit, et al.. (2022). ESCMID rapid guidelines for assessment and management of long COVID. Clinical Microbiology and Infection. 28(7). 955–972. 93 indexed citations
15.
Ong, David S. Y., Paraskevi C. Fragkou, Valentijn A. Schweitzer, et al.. (2021). How to interpret and use COVID-19 serology and immunology tests. Clinical Microbiology and Infection. 27(7). 981–986. 91 indexed citations
16.
Fragkou, Paraskevi C., Charalampos D. Moschopoulos, Emmanouil Karofylakis, Theodoros Kelesidis, & Sotirios Tsiodras. (2021). Update in Viral Infections in the Intensive Care Unit. Frontiers in Medicine. 8. 575580–575580. 17 indexed citations
17.
Fragkou, Paraskevi C., Drifa Belhadi, Nathan Peiffer‐Smadja, et al.. (2020). Review of trials currently testing treatment and prevention of COVID-19. Clinical Microbiology and Infection. 26(8). 988–998. 67 indexed citations
18.
Δουγάς, Γεώργιος, Maria Mavrouli, Georgia Vrioni, et al.. (2019). Antibody Response Following Pre-Exposure Immunization Against Rabies in High-Risk Professionals. Vector-Borne and Zoonotic Diseases. 20(4). 303–309. 3 indexed citations
19.
Moschopoulos, Charalampos D., et al.. (1995). [A unusual cause of acute pancreatitis: obstruction of the afferent loop after gastrectomy according to Bilroth II. Apropos of a case and review of the literature].. PubMed. 38(7-8). 426–9. 2 indexed citations
20.
Moschopoulos, Charalampos D., A Van Gossum, E. Serruys, Fabienne Rickaert, & Michael Adler. (1988). [Endoscopic diagnosis of a cecal ameboma successfully treated with antibiotic therapy].. PubMed. 50(6). 685–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026